PubRank

Matcheri S Keshavan

Author PubWeight™ 236.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008 5.99
2 Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res 2009 3.68
3 Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study. Biol Psychiatry 2002 2.74
4 Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophr Res 2010 2.47
5 Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry 2012 2.33
6 Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res 2005 2.16
7 Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull 2003 2.04
8 Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry 2013 1.85
9 Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 2010 1.80
10 Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013 1.76
11 An MRI study of increased cortical thickness in autism. Am J Psychiatry 2006 1.72
12 Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophr Res 2008 1.71
13 Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv 2009 1.62
14 Increased frontal cortical folding in autism: a preliminary MRI study. Psychiatry Res 2004 1.58
15 Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry 2009 1.56
16 Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophr Bull 2008 1.56
17 MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res 2003 1.54
18 Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013 1.43
19 Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry 2006 1.43
20 Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 2002 1.39
21 Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry 2004 1.38
22 Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr Bull 2009 1.36
23 Deconstructing psychosis with human brain imaging. Schizophr Bull 2007 1.35
24 Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry 2013 1.35
25 A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull 2003 1.34
26 Smaller cingulate volumes in unipolar depressed patients. Biol Psychiatry 2006 1.33
27 A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism. Biol Psychiatry 2009 1.33
28 Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal 2011 1.32
29 Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry 2013 1.31
30 Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia. Schizophr Res 2004 1.30
31 Sex differences in brain maturation in maltreatment-related pediatric posttraumatic stress disorder. Neurosci Biobehav Rev 2003 1.28
32 Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 2004 1.26
33 Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res 2004 1.26
34 Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am J Psychiatry 2005 1.23
35 Anatomical MRI study of borderline personality disorder patients. Psychiatry Res 2004 1.23
36 Disruption of orbitofrontal cortex laterality in offspring from multiplex alcohol dependence families. Biol Psychiatry 2008 1.21
37 An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res 2008 1.20
38 Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry 2004 1.20
39 Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull 2004 1.19
40 Motor performance and anatomic magnetic resonance imaging (MRI) of the basal ganglia in autism. J Child Neurol 2003 1.19
41 Insight and frontal cortical function in schizophrenia: a review. Schizophr Res 2006 1.18
42 "Just the facts": meandering in schizophrenia's many forests. Schizophr Res 2011 1.18
43 Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. Schizophr Bull 2012 1.17
44 Measurement of the orbitofrontal cortex: a validation study of a new method. Neuroimage 2003 1.17
45 Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophr Res 2006 1.16
46 Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am J Psychiatry 2004 1.16
47 Corpus callosum volume in children with autism. Psychiatry Res 2009 1.16
48 Superior temporal gyrus volumes in maltreated children and adolescents with PTSD. Biol Psychiatry 2002 1.14
49 Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychol Med 2006 1.13
50 Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull 2008 1.12
51 Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study. J Affect Disord 2008 1.09
52 Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One 2010 1.09
53 Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005 1.08
54 Cognitive training in mental disorders: update and future directions. Am J Psychiatry 2014 1.07
55 Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. Schizophr Res 2008 1.07
56 Prefrontal subregions and dimensions of insight in first-episode schizophrenia--a pilot study. Psychiatry Res 2005 1.06
57 Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry 2005 1.06
58 Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia. Biol Psychiatry 2005 1.05
59 Corpus callosum volume and neurocognition in autism. J Autism Dev Disord 2009 1.04
60 Volumetric alterations of the orbitofrontal cortex in autism. Prog Neuropsychopharmacol Biol Psychiatry 2006 1.04
61 Dorsolateral prefrontal cortex morphology and short-term outcome in first-episode schizophrenia. Psychiatry Res 2005 1.03
62 Insight and prefrontal cortex in first-episode Schizophrenia. Neuroimage 2004 1.03
63 Magnetic resonance imaging study of corpus callosum abnormalities in patients with bipolar disorder. Biol Psychiatry 2003 1.02
64 Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophr Res 2010 1.02
65 Reduced cortical folding in individuals at high risk for schizophrenia: a pilot study. Schizophr Res 2004 1.02
66 Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. Biol Psychiatry 2012 1.02
67 The entorhinal cortex in first-episode psychotic disorders: a structural magnetic resonance imaging study. Am J Psychiatry 2004 1.02
68 Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry 2002 1.02
69 Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacology 2002 1.01
70 Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia. Biol Psychiatry 2007 1.01
71 Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res 2003 1.01
72 Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia. Schizophr Res 2012 1.01
73 One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophr Res 2010 1.00
74 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004 0.99
75 Subgenual prefrontal cortex of child and adolescent bipolar patients: a morphometric magnetic resonance imaging study. Psychiatry Res 2005 0.99
76 Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia. Biol Psychiatry 2008 0.99
77 Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage 2004 0.99
78 Magnetic resonance imaging study of the orbitofrontal cortex in autism. J Child Neurol 2006 0.98
79 Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression. Psychiatry Res 2009 0.98
80 Abnormal brain size effect on the thalamus in autism. Psychiatry Res 2006 0.98
81 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 2005 0.98
82 Sex difference in cognitive response to antipsychotic treatment in first episode schizophrenia. Neuropsychopharmacology 2007 0.98
83 Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry 2005 0.97
84 Differential processing of metacognitive evaluation and the neural circuitry of the self and others in schizophrenia: a pilot study. Schizophr Res 2010 0.97
85 A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. Res Dev Disabil 2013 0.96
86 Spatiotemporal and frequency domain analysis of auditory paired stimuli processing in schizophrenia and bipolar disorder with psychosis. Psychophysiology 2011 0.96
87 Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized Trial. Res Soc Work Pract 2011 0.96
88 Anatomical MRI study of corpus callosum in unipolar depression. J Psychiatr Res 2004 0.96
89 Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder? Schizophr Res 2010 0.96
90 Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am J Psychiatry 2011 0.94
91 Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction. Schizophr Bull 2013 0.94
92 Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. Psychiatry Res 2010 0.94
93 Disordered corticolimbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by functional magnetic resonance imaging and dynamic causal modeling. Arch Gen Psychiatry 2012 0.93
94 Commonalities in social and non-social cognitive impairments in adults with autism spectrum disorder and schizophrenia. Schizophr Res 2013 0.93
95 Impaired plasmalogens in patients with schizophrenia. Psychiatry Res 2012 0.93
96 Gray matter loss in young relatives at risk for schizophrenia: relation with prodromal psychopathology. Neuroimage 2010 0.93
97 Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr Res 2006 0.93
98 Abnormal left superior temporal gyrus volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Neurosci Lett 2004 0.93
99 Developmental biomarkers in schizophrenia and other psychiatric disorders: common origins, different trajectories? Epidemiol Psichiatr Soc 2006 0.92
100 A two-year longitudinal MRI study of the corpus callosum in autism. J Autism Dev Disord 2012 0.92
101 Inefficiently increased anterior cingulate modulation of cortical systems during working memory in young offspring of schizophrenia patients. J Psychiatr Res 2011 0.92
102 Is early intervention for psychosis feasible and effective? Psychiatr Clin North Am 2012 0.91
103 Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. PLoS One 2013 0.91
104 Developmental abnormalities in striatum in young bipolar patients: a preliminary study. Bipolar Disord 2005 0.91
105 Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia. Schizophr Res 2004 0.91
106 Cortical surface characteristics among offspring of schizophrenia subjects. Schizophr Res 2009 0.91
107 Caudate volume in offspring of patients with schizophrenia. Br J Psychiatry 2007 0.91
108 Orbitofrontal cortex gray matter volumes in bipolar disorder patients: a region-of-interest MRI study. Bipolar Disord 2009 0.91
109 Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers. Prog Neuropsychopharmacol Biol Psychiatry 2011 0.91
110 Decreased coherence in higher frequency ranges (beta and gamma) between central and frontal EEG in patients with schizophrenia: A preliminary report. Psychiatry Res 2005 0.91
111 Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy. Schizophr Res 2013 0.90
112 Sensorimotor transformation deficits for smooth pursuit in first-episode affective psychoses and schizophrenia. Biol Psychiatry 2009 0.90
113 Schneiderian first rank symptoms and inferior parietal lobule cortical thickness in antipsychotic-naïve schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2010 0.90
114 Neurobiological underpinnings of insight deficits in schizophrenia. Int Rev Psychiatry 2007 0.90
115 Pathways to care for African Americans with early psychosis. Psychiatr Serv 2006 0.90
116 Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophr Res 2011 0.90
117 Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neurosci Lett 2008 0.90
118 Enlarged right superior temporal gyrus in children and adolescents with autism. Brain Res 2010 0.90
119 Morphology of the orbitofrontal cortex in first-episode schizophrenia: relationship with negative symptomatology. Prog Neuropsychopharmacol Biol Psychiatry 2007 0.90
120 Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study. Schizophr Res 2007 0.89
121 Abnormal corpus callosum myelination in pediatric bipolar patients. J Affect Disord 2007 0.89
122 Cortical gyrification in autistic and Asperger disorders: a preliminary magnetic resonance imaging study. J Child Neurol 2010 0.89
123 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Int J Neuropsychopharmacol 2011 0.89
124 Evidence of factorial variance of the Mayer-Salovey-Caruso Emotional Intelligence Test across schizophrenia and normative samples. Schizophr Res 2009 0.89
125 COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome. Psychiatry Res 2010 0.89
126 Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia. Neuropsychopharmacology 2008 0.89
127 Associations between purine metabolites and clinical symptoms in schizophrenia. PLoS One 2012 0.89
128 MRI study of the cerebellum in young bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry 2007 0.89
129 Untreated illness duration correlates with gray matter loss in first-episode psychoses. Neuroreport 2009 0.88
130 An MRI study of minor physical anomalies in autism. J Autism Dev Disord 2006 0.88
131 Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophr Res 2002 0.88
132 Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2010 0.88
133 Grey matter and cognitive deficits in young relatives of schizophrenia patients. Neuroimage 2010 0.88
134 Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites. Biol Psychiatry 2002 0.87
135 Classifying antipsychotic agents : need for new terminology. CNS Drugs 2008 0.87
136 Brain gray matter phenotypes across the psychosis dimension. Psychiatry Res 2012 0.87
137 An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008 0.87
138 Impaired associative learning in schizophrenia: behavioral and computational studies. Cogn Neurodyn 2008 0.87
139 Are structural brain abnormalities associated with suicidal behavior in patients with psychotic disorders? J Psychiatr Res 2013 0.87
140 Evidence of developmental alterations in cortical and subcortical regions of children with attention-deficit/hyperactivity disorder: a multivoxel in vivo phosphorus 31 spectroscopy study. Arch Gen Psychiatry 2008 0.87
141 Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia. Psychiatry Res 2008 0.87
142 Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis. Schizophr Res 2009 0.87
143 Investigation of corpus callosum in schizophrenia with diffusion imaging. Schizophr Res 2005 0.87
144 Neurobiology of self-awareness in schizophrenia: an fMRI study. Schizophr Res 2012 0.87
145 Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia. Prostaglandins Leukot Essent Fatty Acids 2003 0.87
146 Do inter-regional gray-matter volumetric correlations reflect altered functional connectivity in high-risk offspring of schizophrenia patients? Schizophr Res 2010 0.86
147 Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings. Child Adolesc Psychiatr Clin N Am 2013 0.86
148 Parahippocampal gyrus in first episode psychotic disorders: a structural magnetic resonance imaging study. Prog Neuropsychopharmacol Biol Psychiatry 2004 0.86
149 Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia. Schizophr Res 2004 0.86
150 Confirmatory factor analysis of the Neurological Evaluation Scale in unmedicated schizophrenia. Psychiatry Res 2005 0.86
151 Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. Neuropsychiatry (London) 2012 0.86
152 Neurodevelopmental basis of bipolar disorder: a critical appraisal. Prog Neuropsychopharmacol Biol Psychiatry 2008 0.86
153 A two-year longitudinal pilot MRI study of the brainstem in autism. Behav Brain Res 2013 0.86
154 White matter hyperintensities in bipolar and unipolar patients with relatively mild-to-moderate illness severity. J Affect Disord 2003 0.86
155 Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia. Arch Gen Psychiatry 2008 0.86
156 Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis. Front Cell Neurosci 2013 0.86
157 Reduced intra-amygdala activity to positively valenced faces in adolescent schizophrenia offspring. Schizophr Res 2010 0.85
158 Verbal fluency deficits and altered lateralization of language brain areas in individuals genetically predisposed to schizophrenia. Schizophr Res 2009 0.85
159 Emotional words induce enhanced brain activity in schizophrenic patients with auditory hallucinations. Psychiatry Res 2006 0.85
160 Regionally specific alterations in membrane phospholipids in children with ADHD: An in vivo 31P spectroscopy study. Psychiatry Res 2006 0.85
161 Neurobiology of self-awareness deficits in schizophrenia: A hypothetical model. Asian J Psychiatr 2011 0.85
162 A preliminary longitudinal volumetric MRI study of amygdala and hippocampal volumes in autism. Prog Neuropsychopharmacol Biol Psychiatry 2013 0.85
163 Abnormalities of the corpus callosum in non-psychotic high-risk offspring of schizophrenia patients. Psychiatry Res 2010 0.85
164 Brief report: abnormal association between the thalamus and brain size in Asperger's disorder. J Autism Dev Disord 2007 0.84
165 Neuroanatomical substrates of foresight in schizophrenia. Schizophr Res 2008 0.84
166 Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy. Psychiatry Res 2013 0.84
167 Classification of psychotic disorders: need to move toward a neuroscience-informed nosology. Asian J Psychiatr 2013 0.84
168 Insular volumes in first-episode schizophrenia: gender effect. Schizophr Res 2005 0.84
169 Association of variants in DRD2 and GRM3 with motor and cognitive function in first-episode psychosis. Eur Arch Psychiatry Clin Neurosci 2013 0.84
170 Dorsolateral prefrontal cortex magnetic resonance imaging measurements and cognitive performance in autism. J Child Neurol 2010 0.83
171 Fronto-parietal hypo-activation during working memory independent of structural abnormalities: conjoint fMRI and sMRI analyses in adolescent offspring of schizophrenia patients. Neuroimage 2011 0.83
172 Pituitary volume in treatment-naïve pediatric major depressive disorder. Biol Psychiatry 2006 0.83
173 Brain activation patterns during visual episodic memory processing among first-degree relatives of schizophrenia subjects. Neuroimage 2012 0.83
174 1H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. Psychiatry Res 2005 0.83
175 Early prodromal symptoms can predict future psychosis in familial high-risk youth. J Psychiatr Res 2011 0.83
176 Pituitary volume in pediatric obsessive-compulsive disorder. Biol Psychiatry 2005 0.83
177 Diagnostic specificity and familiality of early versus late evoked potentials to auditory paired stimuli across the schizophrenia-bipolar psychosis spectrum. Psychophysiology 2014 0.83
178 Relationships between cognitive and neurological performance in neuroleptic-naïve psychosis. J Neuropsychiatry Clin Neurosci 2004 0.83
179 Reduced central white matter volume in autism: implications for long-range connectivity. Psychiatry Clin Neurosci 2010 0.83
180 Social and neuro-cognition as distinct cognitive factors in schizophrenia: a systematic review. Schizophr Res 2013 0.83
181 Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup. Schizophr Bull 2004 0.82
182 Can psychiatrists recognize mental illness in paintings? Am J Psychiatry 2006 0.82
183 Foresight in schizophrenia: a potentially unique and relevant factor to functional disability. Psychiatr Serv 2008 0.82
184 Hypo-activation in the executive core of the sustained attention network in adolescent offspring of schizophrenia patients mediated by premorbid functional deficits. Psychiatry Res 2011 0.82
185 No difference in the prevalence of cavum septum pellucidum (CSP) between first-episode schizophrenia patients, offspring of schizophrenia patients and healthy controls. Schizophr Res 2008 0.82
186 The neural correlates of performance in adolescents at risk for schizophrenia: inefficiently increased cortico-striatal responses measured with fMRI. J Psychiatr Res 2011 0.82
187 Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia. Psychopharmacology (Berl) 2014 0.81
188 Subclinical delusional thinking predicts lateral temporal cortex responses during social reflection. Soc Cogn Affect Neurosci 2012 0.81
189 Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention. Early Interv Psychiatry 2013 0.81
190 Effects of word frequency on semantic memory in schizophrenia: electrophysiological evidence for a deficit in linguistic access. Int J Psychophysiol 2009 0.80
191 Progressive alterations of the auditory association areas in young non-psychotic offspring of schizophrenia patients. J Psychiatr Res 2010 0.80
192 Approaches for adolescents with an affected family member with schizophrenia. Curr Psychiatry Rep 2004 0.80
193 Pituitary volume in neuroleptic-naïve schizophrenia: a structural MRI study. Schizophr Res 2006 0.80
194 Prefrontal cortical dysfunction during visual perspective-taking in schizophrenia. Schizophr Res 2013 0.80
195 An MRI-based approach for the measurement of the dorsolateral prefrontal cortex in humans. Psychiatry Res 2009 0.80
196 Corpus callosum deficits in antipsychotic-naïve schizophrenia: evidence for neurodevelopmental pathogenesis. Psychiatry Res 2010 0.80
197 Neuropsychological performance and regional cerebral blood flow in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2003 0.80
198 Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia. J Clin Psychiatry 2009 0.79
199 Grey matter changes associated with host genetic variation and exposure to Herpes Simplex Virus 1 (HSV1) in first episode schizophrenia. Schizophr Res 2010 0.79
200 Feasibility and preliminary efficacy data from a computerized cognitive intervention in children with chromosome 22q11.2 deletion syndrome. Res Dev Disabil 2013 0.79
201 Reduced subicular subdivisions of the hippocampal formation and verbal declarative memory impairments in young relatives at risk for schizophrenia. Schizophr Res 2013 0.78
202 Genetic Sources of Subcomponents of Event-Related Potential in the Dimension of Psychosis Analyzed From the B-SNIP Study. Am J Psychiatry 2015 0.78
203 Prevention and recovery in early psychosis (PREP(®)): building a public-academic partnership program in Massachusetts, United States. Asian J Psychiatr 2013 0.78
204 Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2012 0.78
205 Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study. Biol Psychiatry 2003 0.78
206 Enhancing putative mirror neuron activity with magnetic stimulation: a single-case functional neuroimaging study. Biol Psychiatry 2013 0.78
207 Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. Biol Psychiatry 2012 0.78
208 Obstetric complications correlate with neurobehavioral and brain structural alterations in young relatives at risk for schizophrenia. Ann N Y Acad Sci 2003 0.78
209 Family history of psychosis moderates early auditory cortical response abnormalities in non-psychotic bipolar disorder. Bipolar Disord 2013 0.78
210 High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia. Psychiatry Res 2010 0.77
211 Alterations in the cerebral white matter of genetic high risk offspring of patients with schizophrenia spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012 0.77
212 Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia. Schizophr Res 2005 0.77
213 Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2006 0.77
214 Insight into illness in patients and caregivers during early psychosis: a pilot study. Schizophr Res 2011 0.77
215 Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia. Psychiatry Res 2012 0.77
216 Newer techniques in magnetic resonance imaging and their potential for neuropsychiatric research. J Psychosom Res 2002 0.77
217 Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up. Schizophr Res 2013 0.77
218 1H MRS brain measures and acute lorazepam administration in healthy human subjects. Neuropsychopharmacology 2002 0.77
219 Heart rate variability in patients with depression. Arch Gen Psychiatry 2007 0.76
220 The effects of antipsychotic medication on factor and cluster structure of neurologic examination abnormalities in schizophrenia. Schizophr Res 2005 0.76
221 Neurobiology of the early course of schizophrenia. Expert Rev Neurother 2008 0.76
222 Validation of Social Cognition Rating Tools in Indian Setting (SOCRATIS): A new test-battery to assess social cognition. Asian J Psychiatr 2011 0.76
223 Prolonged hemodynamic response during incidental facial emotion processing in inter-episode bipolar I disorder. Brain Imaging Behav 2014 0.76
224 Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients. J Clin Psychopharmacol 2007 0.76
225 MRI study of corpus callosum in patients with borderline personality disorder: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2007 0.76
226 Reduced platelet serotonergic responsivity as assessed by dense granule secretion in first-episode psychosis. Clin Biochem 2007 0.76
227 Involuntary movements and their correlates in first-episode psychoses. Acta Neuropsychiatr 2010 0.76
228 Increased corpus callosum volume in children with chromosome 22q11.2 deletion syndrome is associated with neurocognitive deficits and genetic polymorphisms. Eur J Hum Genet 2012 0.76
229 Violence and mental illness. Asian J Psychiatr 2013 0.75
230 Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders: response to Cohen et al. Diabetes Care 2007 0.75
231 Need for culture specific tools to assess social cognition in schizophrenia. Schizophr Res 2011 0.75
232 Critical role of M3 muscarinic receptor in insulin secretion: implications for psychopharmacology. J Clin Psychopharmacol 2006 0.75
233 Spirituality and positive mental health. Asian J Psychiatr 2012 0.75
234 Mohan Agashe, M.D. eminent psychiatrist and veteran actor. Asian J Psychiatr 2013 0.75
235 Schizophrenia complicated by chronic hepatitis C virus and hepatic encephalopathy. Am J Psychiatry 2014 0.75
236 Asian pearls. Asian J Psychiatr 2009 0.75
237 Physical and neurologic examinations in neuropsychiatry. Semin Clin Neuropsychiatry 2002 0.75
238 The 7 sins of psychopharmacology. J Clin Psychopharmacol 2010 0.75
239 DSM-5 and incremental progress in psychiatric nosology. Asian J Psychiatr 2013 0.75
240 An international journal for psychiatry in Asia. Asian J Psychiatr 2008 0.75
241 Urinary pH in panic disorder. Psychiatry Res 2005 0.75
242 Medical education corner They taught us. Asian J Psychiatr 2009 0.75
243 Psychiatric genetics research in Asia. Asian J Psychiatr 2012 0.75
244 The Massachusetts Mental Health Center: going forward after 100 years. Am J Psychiatry 2012 0.75
245 Psychotherapy in the Bhagavad Gita, the Hindu scriptural text. Am J Psychiatry 2014 0.75
246 Normal pituitary volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Depress Anxiety 2004 0.75